TW200813070A - Antiviral agents - Google Patents

Antiviral agents Download PDF

Info

Publication number
TW200813070A
TW200813070A TW096125693A TW96125693A TW200813070A TW 200813070 A TW200813070 A TW 200813070A TW 096125693 A TW096125693 A TW 096125693A TW 96125693 A TW96125693 A TW 96125693A TW 200813070 A TW200813070 A TW 200813070A
Authority
TW
Taiwan
Prior art keywords
substituted
group
methyl
compound
amino
Prior art date
Application number
TW096125693A
Other languages
English (en)
Chinese (zh)
Inventor
Franz Ulrich Schmitz
Christopher Don Roberts
Ronald Conrad Griffith
Janos Botyanszki
Son Minh Pham
Original Assignee
Genelabs Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genelabs Tech Inc filed Critical Genelabs Tech Inc
Publication of TW200813070A publication Critical patent/TW200813070A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
TW096125693A 2006-07-14 2007-07-13 Antiviral agents TW200813070A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83104006P 2006-07-14 2006-07-14

Publications (1)

Publication Number Publication Date
TW200813070A true TW200813070A (en) 2008-03-16

Family

ID=38742551

Family Applications (1)

Application Number Title Priority Date Filing Date
TW096125693A TW200813070A (en) 2006-07-14 2007-07-13 Antiviral agents

Country Status (13)

Country Link
EP (1) EP2044083A1 (pt)
JP (1) JP2009543807A (pt)
KR (1) KR20090033881A (pt)
CN (1) CN101490058A (pt)
AR (1) AR062258A1 (pt)
AU (1) AU2007272441A1 (pt)
BR (1) BRPI0714346A2 (pt)
CA (1) CA2657651A1 (pt)
MX (1) MX2009000513A (pt)
PE (1) PE20080427A1 (pt)
RU (1) RU2009105196A (pt)
TW (1) TW200813070A (pt)
WO (2) WO2008008907A2 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070049593A1 (en) 2004-02-24 2007-03-01 Japan Tobacco Inc. Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor
US7659263B2 (en) 2004-11-12 2010-02-09 Japan Tobacco Inc. Thienopyrrole compound and use thereof as HCV polymerase inhibitor
ES2381410T3 (es) 2007-05-04 2012-05-28 Vertex Pharmceuticals Incorporated Terapia de combinación paa el tratamiento de infecciones por VHC
BR112012014899A2 (pt) 2009-12-18 2017-03-14 Idenix Pharmaceuticals Inc composto, composição farmacêutica, método para tratar ou prevenir uma infecção por vírus de hepatite c em um sujeito, método para tratar , prevenir ou melhorar um ou mais sintomas de uma doença hepática ou distúrbio associado a uma infecção por vírus de hepatite c em um sujeito, método para inibir a replicação de um vírus em um hospedeiro, método para inibir a replicação de um vírus
EP2655362A1 (en) * 2010-12-22 2013-10-30 Abbvie Inc. Hepatitis c inhibitors and uses thereof
US20120252721A1 (en) * 2011-03-31 2012-10-04 Idenix Pharmaceuticals, Inc. Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
FR3008975A1 (fr) 2013-07-23 2015-01-30 Servier Lab Nouveaux derives de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
RU2546006C1 (ru) 2014-03-07 2015-04-10 Римма Ильинична Ашкинази Противовирусное средство
EP3248596B1 (en) 2015-01-20 2023-12-06 Tets, Viktor Veniaminovich Hemostatic agent
US10167293B2 (en) * 2016-05-26 2019-01-01 Bayer Pharma Aktiengesellschaft [8-(phenylsulfonyl)-3,8-diazabicyclo[3.2.1]oct-3-yl](1H-1,2,3-triazol-4-yl)methanones
CN111093646A (zh) 2017-05-24 2020-05-01 维克托·韦尼阿米诺维奇·泰茨 分级分离的抗微生物组合物及其用途
TW202302598A (zh) 2021-04-16 2023-01-16 美商基利科學股份有限公司 噻吩并吡咯化合物
WO2023039464A1 (en) 2021-09-10 2023-03-16 Gilead Sciences, Inc. Thienopyrrole compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1401825E (pt) * 2001-06-11 2009-10-23 Virochem Pharma Inc Compostos e métodos para o tratamento ou para a prevenção de infecções com flavivírus
WO2004108687A2 (en) * 2003-06-04 2004-12-16 Genelabs Technologies, Inc. Nitrogen-containing heteroaryl derivatives for the treatment of hcv-infection

Also Published As

Publication number Publication date
WO2008008912A1 (en) 2008-01-17
AU2007272441A1 (en) 2008-01-17
EP2044083A1 (en) 2009-04-08
AR062258A1 (es) 2008-10-29
BRPI0714346A2 (pt) 2013-03-19
CN101490058A (zh) 2009-07-22
CA2657651A1 (en) 2008-01-17
KR20090033881A (ko) 2009-04-06
RU2009105196A (ru) 2010-08-27
MX2009000513A (es) 2009-03-09
WO2008008907A3 (en) 2008-03-20
JP2009543807A (ja) 2009-12-10
WO2008008907A2 (en) 2008-01-17
AU2007272441A2 (en) 2009-03-19
PE20080427A1 (es) 2008-06-11

Similar Documents

Publication Publication Date Title
TW200813070A (en) Antiviral agents
KR101653548B1 (ko) 2-｛4-［（3ｓ）-피페리딘-3-일］페닐｝-2ｈ-인다졸-7-카복스아미드의 약제학적으로 허용되는 염
ES2524787T3 (es) Derivados de piridazinona como inhibidores de PARP
JP4616831B2 (ja) Ａｋｔ活性の阻害剤
US20060211698A1 (en) Bicyclic heteroaryl derivatives for treating viruses
TW591022B (en) Tetrahydropyridino or piperidino heterocyclic derivatives
US20060264430A1 (en) Pyrazole derivative
CA2613261A1 (en) Heteroaryl derivatives for treating viruses
KR20070096038A (ko) Ｍｇｌｕｒ５ 길항제로서 사용하기 위한 피롤리딘 및피페리딘 아세틸렌 유도체
JP2009544622A (ja) 多環式ウイルス阻害剤
US20190263828A1 (en) Heteroaromatic compounds as vanin inhibitors
WO2005049622A1 (ja) ５－５員縮合複素環化合物及びそのｈｃｖポリメラーゼ阻害剤としての用途
TW200526606A (en) Substituted triazole derivatives as oxytocin antagonists
US9533999B2 (en) Fused thiazin-3-ones as KCA3.1 inhibitors
AU2016341259A1 (en) Pyridone derivatives and their use as kinase inhibitors
US20080051384A1 (en) Antiviral agents